Cargando…
Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial
BACKGROUND: This trial aimed to evaluate the anti-obesity effects and safety of Neoagaro-oligosaccharides (NAOs) in humans in a 16 week, randomized, double-blind, placebo-controlled clinical trial. METHODS: One hundred overweight or obese subjects with a body mass index of 23 to 34.9 kg/m(2) and a p...
Autores principales: | Baek, Hyang-Im, Ha, Ki-Chan, Park, Yu Kyung, Lee, Je Hyeon, Kim, Eun Joo, Ko, Hye-Jeong, Joo, Jong Cheon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585797/ https://www.ncbi.nlm.nih.gov/pubmed/37858097 http://dx.doi.org/10.1186/s12906-023-04206-2 |
Ejemplares similares
-
The Potential of Neoagaro-Oligosaccharides as a Treatment of Type II Diabetes in Mice
por: Lin, Fudi, et al.
Publicado: (2019) -
Quantification of Neoagaro-Oligosaccharide Production through Enzymatic Hydrolysis and Its Anti-Oxidant Activities
por: Xu, Shu-Ying, et al.
Publicado: (2018) -
Production of Neoagaro-Oligosaccharides With Various Degrees of Polymerization by Using a Truncated Marine Agarase
por: Qu, Wu, et al.
Publicado: (2020) -
Neoagaro-oligosaccharide monomers inhibit inflammation in LPS-stimulated macrophages through suppression of MAPK and NF-κB pathways
por: Wang, Wei, et al.
Publicado: (2017) -
Neoagaro-Oligosaccharides Ameliorate Chronic Restraint Stress-Induced Depression by Increasing 5-HT and BDNF in the Brain and Remodeling the Gut Microbiota of Mice
por: Zhuang, Yan, et al.
Publicado: (2022)